Learn
Is this exceptional? The checklist
The same five structural tests every piece in the Exceptional Company Series runs — turned into what to actually look at on a filing, not just what the test is called.
Download the checklist (PDF) →
One page. Print it, or keep it beside the filing.
Before the five tests
- Classify it first
- Fast grower, steady compounder, cyclical, turnaround, or asset play. The same five tests do not mean the same thing across types — a cyclical's worst drawdown is supposed to look worse than a steady compounder's.
- Say what it does, in one sentence
- If you cannot, you do not know it well enough to hold it through a fall. Not what the industry does — what this company actually earns money doing.
- Name the moat's mechanism
- Switching cost, network effect, scale, brand, regulation. “It's a great business” is not a moat. Saying how is.
The five tests
1
Compounding
— is growth real, and repeatable?- 10+ years of earnings history, not two or three good ones
- The CAGR over the whole period, not just the trailing twelve months
- The % of periods with earnings up — not just the average growth rate
- The worst drawdown in earnings (not the share price) — how bad did the single worst year actually get?
2
Earnings quality
— cash-backed, or engineered?- Does free cash flow track reported earnings, or quietly diverge from them?
- The margin trend — expanding, stable, or eroding under the surface?
- How much of “earnings” is the operating business, versus one-offs — buybacks, tax credits, asset sales?
3
Balance sheet
— could it survive a bad decade?- Net debt to equity — low, or net cash?
- Interest coverage — how many times over can operating income pay the interest?
- Would a real recession break it, or just slow it down?
4
Capital allocation
— is the cash deployed sensibly?- Where does free cash actually go — reinvestment, dividends, buybacks, debt paydown?
- Track record on acquisitions — value-additive, or empire-building?
- Are buybacks made below or above what the business is actually worth?
5
Per-share value
— does the compounding reach the shareholder?- Is the share count shrinking (buybacks) or growing (dilution)?
- Does EPS growth match net income growth, or is a shrinking share count doing the work alone?
After the five tests
- What would have to go wrong
- Name the bear case before you are in the position, not after. If you cannot state the strongest argument against it, you have not finished the work.
- Exceptional does not mean cheap
- “Is this a good business” and “is this a good price” are two separate questions, answered two separate ways. This checklist only answers the first one — why that distinction costs real money to ignore.
A business can clear every test on this page and still be the wrong price. That is not a flaw in the checklist — it is a checklist for one question, answered honestly, which is worth more than a checklist that quietly answers two and only tells you about one of them.
General explanation of a method, not personal advice, and not a recommendation to buy or sell anything. Terms used here are defined in Key terms.